Somatostatin Receptor Type 4 Market by Type (NTX-0290, NNC-26910, Veldoreotide), by Application (Chronic Pain, Acromegaly, Neuropathic Pain, Alzheimer’s Disease, Cognitive Disorder, Dementia, Diabetic Retinopathy, Gastrointestinal Tumor, Neuroendocrine Tumors, Pancreatic Tumor, Pituitary ACTH Hypersecretion); by Regional outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 - 2026
Report ID :AMI-121 | Category : Therapeutic Area | Published Date : August, 2018 | Pages : 187 | Format :PDF